|
End-of-day quote
Shanghai S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 14.00 CNY | +1.89% |
|
+2.34% | -7.10% |
| 09-02 | CICC Starts Tasly Pharmaceutical Group at Outperform with 17.80 Yuan Price Target | MT |
| 08-24 | Tasly Pharmaceutical to Buy 4 Billion Yuan of Wealth Management Products | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TASLY PHARMACEUTICAL GROUP CO., LTD | Alternative Medicine | +1.89% | +2.34% | -7.10% | -11.39% | +5.26% | 3.12B |  |  | |
- Stock Market
- Stocks
- 600535 Stock
- Charts Tasly Pharmaceutical Group Co., Ltd
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
